Related Experiment Video
Updated: Jul 31, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
Published on: September 20, 2011
Mesoporous carbon nanoparticles capped with polyacrylic acid as drug carrier for bi-trigger continuous drug release
Yang Zhang1, Lu Han, Lin-Lin Hu
1Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Box 332, Shenyang 110819, China. herh@mail.neu.edu.cn jianhuajrz@mail.neu.edu.cn.
Abstract:
A pH and redox responsive bi-trigger continuous drug release nanocarrier is developed by capping mesoporous carbon nanoparticles (MCNs) with polyacrylic acid (PAA), termed as PAA-ss-MCN. The nanocarrier contains disulfide bond units and exhibits pH responsive behavior. It provides promising potential for drug loading due to the internal uniform channels and large surface area of MCNs. PAA grafted on the exterior surface of MCNs acts as a gating layer, generating a novel nano-container and a pH-responsive intelligent nanovalve. By loading doxorubicin (DOX) in PAA-ss-MCN, its sequential release is achieved via two approaches: (1) the intracellular acidic environment induces partial release from the surface of the PAA gating layer, (2) release of the drug sealed in nanochannels via disruption of the integrity of the nanocarrier by glutathione (GSH) caused dissociation of disulfide bonds in the physiological environment. As a result, release of 62% loaded drug is readily achieved. After culturing with HeLa cells, DOX transports into the cell interior and therein exhibits pH- and GSH-sensitive release. As most tumor sites exhibit more acidic environments or high redox potential, the pH- and GSH-sensitive releasing capability of PAA-ss-MCN is particularly useful for controllable drug delivery by taking advantage of the inherent characteristics of tumor cells.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Stimuli-Activated
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Delayed-Release Systems

